Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

During the Trading Day
3.29 -0.12 / -3.52%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.30 +0.01 / +0.30%
Volume: 500.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3
Quarter 4
Quarter 1
Quarter 2
Revenue and IncomeNet Revenues735.5K729.1K2.6M55.8K
Cost of Goods Sold45.4K23.0K37.5K34.2K
Depreciation And Amortization1.9K1.7K1.8K1.4K
Operating ExpensesGross Income688.2K704.4K2.5M20.2K
General Expenses1.4M1.4M915.6K23.2M
Research And Development897.5K737.3K557.5K482.7K
Total Operating Expenses1.5M1.4M954.9K23.3M
Non-Operating ExpensesOperating Income-734.3K-710.9K1.6M-23.2M
Extraordinary Credit0.00189.6K0.000.00
Interest Expense On Debt0.0070.7K52.5K56.9K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-725.0K-592.0K1.6M-23.3M
Income Taxes-36.8K-99.2K0.000.00
Net Income-688.2K-492.8K1.6M-23.3M
Shares To Calculate EPSShares To Calculate EPS35.4M35.9M36.3M37.2M
Shares To Calculate EPS Diluted35.4M35.9M38.3M37.2M
Earnings Per ShareEPS-$0.02-$0.02$0.04-$0.63
EPS Diluted-$0.02-$0.01$0.04-$0.63